1 active not recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Diffuse Large B-cell-lymphoma: new trials by email Literature Review of Diffuse Large B-cell-lymphoma trials Research Report on Diffuse Large B-cell-lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Venetoclax Plus R-ICE Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma Venetoclax, Rituximab, Ifosfamide - Diffuse Large B-cell-lymphoma | Phase 1 / Phase 2 | Active not recruiting | Molly Gallogly | 65 | 2017-06-26 | 2022-11-16 |
Dendritic Cell Sarcoma, Interdigitating (1)
Hemic and Lymphatic Diseases (1) · Histiocytic Disorders, Malignant (1) · Histiocytosis (1) · Lymphatic Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Carboplatin (1) · Etoposide (1) · Ifosfamide (1) · Rituximab (1) · venetoclax (1)
Molly Gallogly (1)
United States (1)